Clincosm LogoSign in Get a demo

haematologic disease

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Multiple Myeloma in Relapse, Tumors Trial (Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +8 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 13, 2022

Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 11, 2022

Multiple Myeloma, Tumors, Tumors, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Mar 4, 2022

Hemophilia B, Blood Coagulation Disorders, Inherited, Blood Coagulation Disorder Trial in Worldwide

Recruiting
  • Hemophilia B
  • +3 more
    • Phoenix, Arizona
    • +55 more
    Dec 6, 2021

    Haematologic Disease, Haematological Malignancy Trial in Italy (clinical data and sample collection)

    Recruiting
    • Haematologic Disease
    • Haematological Malignancy
    • clinical data and sample collection
    • Meldola, FC, Italy
    • +4 more
    Feb 25, 2021

    Surgery, Multiorgan Failure, Haematologic Disease Trial in Ostrava (CHG technique, HMG technique)

    Completed
    • Surgery
    • +2 more
    • CHG technique
    • HMG technique
    • Ostrava, Moravian-Silesian Region, Czechia
      University Hospital Ostrava
    Mar 13, 2019